RYTM

RYTM Operating Expenses

$414.16MTTM · USD

Period ending:

RYTM FY Operating ExpensesUSD
RYTM FY Operating Expenses2012-12-31: $18.14M2013-12-31: $21.45M2014-12-31: $6.49M2015-12-31: $10.57M2016-12-31: $25.91M2017-12-31: $32.41M2018-12-31: $78.42M2019-12-31: $145.17M2020-12-31: $135.89M2021-12-31: $172.61M2022-12-31: $200.66M2023-12-31: $252.48M2024-12-31: $382.26M2025-12-31: $362.28M$382.26M$0.00
2012-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

RYTM operating expenses history

Expenses from normal business operations (SG&A, R&D, etc.). The available annual fiscal periods series contains 14 observations from Dec 31, 2012 to Dec 31, 2025.

Rhythm Pharmaceuticals Inc Operating Expenses — Annual fiscal periods (USD)
Period endingOperating Expenses (USD)
362,281,000
382,261,000
252,483,000
200,662,000
172,614,000
135,885,000
145,166,000
78,417,000
32,412,000
25,905,000
10,573,000
6,493,000
21,448,000
18,138,000

Compare operating expenses

All RYTM financial metrics · RYTM stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.